Company intelligence / Profile preview

SkillCell

Jarry (Guadeloupe), France

Ownership: Private
Employees: ~12
Development stage: Other

Overview

SkillCell has commercial, CE-marked in vitro diagnostic tests including IDIR, a urine test for insulin-resistance identification, and EasyCOV, a saliva molecular test for Covid-19, based on its programmable non-living biomachine synthetic biology platform.[1][3][6][8]

Therapeutic areas: EndocrinologyInfectious Diseases
Modalities: DeviceDiagnostic testNon-pharmacological therapy
Industry: Molecular Diagnostics

Partnerships

CNRS laboratory Sys2Diag (synthetic biology and diagnostics R&D collaboration)[1][2][6]CEA Frédéric Joliot institute (enzyme research collaboration)[1]Montpellier CHU / University Hospital Center of Montpellier (clinical collaboration for insulin resistance urine test)[1]VOGO (consortium partner for EasyCOV development and industrialization)[6][8]

Beyond the preview

Go deeper on SkillCell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkillCell.

Explore the full profile